10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2020 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 16, 2021) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Revenues: | |||
| Premiums | $ 69,364 | 63,122 | 8,184 |
| Net investment income | 798 | 1,011 | 660 |
| Total revenues | 268,706 | 256,776 | 194,579 |
| Operating costs: | |||
| Cost of products sold | 163,981 | 158,719 | 156,447 |
| Benefit costs | 55,679 | 52,529 | 6,594 |
| Goodwill impairments | 0 | 0 | 6,149 |
| Operating expenses | 35,135 | 33,541 | 21,368 |
| Total operating costs | 254,795 | 244,789 | 190,558 |
| Operating income | 13,911 | 11,987 | 4,021 |
| Interest expense | 2,907 | 3,035 | 2,619 |
| Loss on early extinguishment of debt | 1,440 | 79 | 0 |
| Other income | (206) | (124) | (4) |
| Income before income tax provision | 9,770 | 8,997 | 1,406 |
| Income tax provision | 2,569 | 2,366 | 2,002 |
| Income (loss) from continuing operations | 7,201 | 6,631 | (596) |
| Loss from discontinued operations, net of tax | (9) | 0 | 0 |
| Net income (loss) | 7,192 | 6,631 | (596) |
| Net (income) loss attributable to noncontrolling interests | (13) | 3 | 2 |
| Net income (loss) attributable to CVS Health | 7,179 | 6,634 | (594) |
| Basic earnings (loss) per share: | |||
| Income (loss) from continuing operations attributable to CVS Health (in dollars per share) | 5.49 | 5.10 | (0.57) |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | (0.01) | 0.00 | 0.00 |
| Net income (loss) attributable to CVS Health (in dollars per share) | 5.48 | 5.10 | (0.57) |
| Weighted average basic shares outstanding (in shares) | 1,309 | 1,301 | 1,044 |
| Diluted earnings (loss) per share: | |||
| Income (loss) from continuing operations attributable to CVS Health (in dollars per share) | 5.47 | 5.08 | (0.57) |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | (0.01) | 0.00 | 0.00 |
| Net income (loss) attributable to CVS Health (in dollars per share) | 5.46 | 5.08 | (0.57) |
| Weighted average diluted shares outstanding (in shares) | 1,314 | 1,305 | 1,044 |
| Dividends declared per share (in dollars per share) | 2.00 | 2.00 | 2.00 |
| Cost, Product and Service [Extensible List] | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember |
| Product and Service | |||
| Products | |||
| Revenue from Products and Services | 190,688 | 185,236 | 183,910 |
| Services | |||
| Revenue from Products and Services | 7,856 | 7,407 | 1,825 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |